Amgen Named One of the 2026 World’s Most Ethical Companies® by Ethisphere - Amgen
Amgen Named One of the 2026 World’s Most Ethical Companies® by Ethisphere Amgen
Amgen Company News
Nova R Wealth Inc. Grows Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Nova R Wealth Inc. Grows Stock Holdings in Amgen Inc. $AMGN MarketBeat
Amgen’s Repatha Data Reinforces Cardiovascular Franchise And Valuation Debate - simplywall.st
Amgen’s Repatha Data Reinforces Cardiovascular Franchise And Valuation Debate simplywall.st
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock - Yahoo Finance
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock Yahoo Finance
Vanguard Group reports zero Amgen (AMGN) holdings after internal realignment - Stock Titan
Vanguard Group reports zero Amgen (AMGN) holdings after internal realignment Stock Titan
Amgen Acquires Oxford Spinout Dark Blue Therapeutics in Up to $840M Deal to Advance AML Treatment - Oncodaily
Amgen Acquires Oxford Spinout Dark Blue Therapeutics in Up to $840M Deal to Advance AML Treatment Oncodaily
Amgen Named to Forbes’ 2026 List of America’s Best Large Employers - Amgen
Amgen Named to Forbes’ 2026 List of America’s Best Large Employers Amgen
Global X Japan Co. Ltd. Has $6.80 Million Position in Amgen Inc. $AMGN - MarketBeat
Global X Japan Co. Ltd. Has $6.80 Million Position in Amgen Inc. $AMGN MarketBeat
Amgen Inc. (AMGN): Billionaire Ken Fisher Doubles Bullish Position - Yahoo Finance
Amgen Inc. (AMGN): Billionaire Ken Fisher Doubles Bullish Position Yahoo Finance
Dakota Wealth Management Acquires 4,581 Shares of Amgen Inc. $AMGN - MarketBeat
Dakota Wealth Management Acquires 4,581 Shares of Amgen Inc. $AMGN MarketBeat
2025 at Amgen: Investing, Expanding, and Serving More Patients - Amgen
2025 at Amgen: Investing, Expanding, and Serving More Patients Amgen
Amgen Inc. $AMGN Shares Purchased by Czech National Bank - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Czech National Bank MarketBeat
Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report - Amgen
Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report Amgen
Pensionfund Sabic Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Pensionfund Sabic Makes New Investment in Amgen Inc. $AMGN MarketBeat
Amgen Once Again Recognized as Top Pharma Company by U.S. Patients - Amgen
Amgen Once Again Recognized as Top Pharma Company by U.S. Patients Amgen
National Wealth Management Group LLC Makes New $1.53 Million Investment in Amgen Inc. $AMGN - MarketBeat
National Wealth Management Group LLC Makes New $1.53 Million Investment in Amgen Inc. $AMGN MarketBeat
Amgen Breaks Ground on $600 Million Center for Science and Innovation in Thousand Oaks, Calif. - Amgen
Amgen Breaks Ground on $600 Million Center for Science and Innovation in Thousand Oaks, Calif. Amgen
Assenagon Asset Management S.A. Sells 59,138 Shares of Amgen Inc. $AMGN - MarketBeat
Assenagon Asset Management S.A. Sells 59,138 Shares of Amgen Inc. $AMGN MarketBeat
Clear Trail Advisors LLC Takes Position in Amgen Inc. $AMGN - MarketBeat
Clear Trail Advisors LLC Takes Position in Amgen Inc. $AMGN MarketBeat
Amgen Inc. $AMGN Shares Sold by E. Ohman J or Asset Management AB - MarketBeat
Amgen Inc. $AMGN Shares Sold by E. Ohman J or Asset Management AB MarketBeat
Avanza Fonder AB Increases Holdings in Amgen Inc. $AMGN - MarketBeat
Avanza Fonder AB Increases Holdings in Amgen Inc. $AMGN MarketBeat
Large pharma companies reduced headcounts by more than 22K in 2025 as $300B patent cliff looms - Fierce Pharma
Large pharma companies reduced headcounts by more than 22K in 2025 as $300B patent cliff looms Fierce Pharma
In diabetes patients, Repatha cut first major heart event risk 31% - Stock Titan
In diabetes patients, Repatha cut first major heart event risk 31% Stock Titan
Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026 - Amgen
Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026 Amgen
Amgen's Imdylltra heads list of CHMP recommendations - FirstWord Pharma
Amgen's Imdylltra heads list of CHMP recommendations FirstWord Pharma
SG Americas Securities LLC Acquires 113,909 Shares of Amgen Inc. $AMGN - MarketBeat
SG Americas Securities LLC Acquires 113,909 Shares of Amgen Inc. $AMGN MarketBeat
Bio Meets Tech: How Amgen is Designing the Medicines of Tomorrow - Amgen
Bio Meets Tech: How Amgen is Designing the Medicines of Tomorrow Amgen
Amgen Patient Advocacy and Strategic Alliances - Amgen
Amgen Patient Advocacy and Strategic Alliances Amgen
Amgen Inc. (AMGN) Collaborates on Ending Anti-OX40 Clinical Studies - Yahoo Finance
Amgen Inc. (AMGN) Collaborates on Ending Anti-OX40 Clinical Studies Yahoo Finance
Amgen Inc. (AMGN) Completes Phase 3 Trial for ABP 206 Opdivo Biosimilar Candidate - Yahoo Finance
Amgen Inc. (AMGN) Completes Phase 3 Trial for ABP 206 Opdivo Biosimilar Candidate Yahoo Finance
How Amgen Uses AI to Support Patient Access & Reimbursement - Amgen
How Amgen Uses AI to Support Patient Access & Reimbursement Amgen
Marshall Financial Group LLC Purchases New Position in Amgen Inc. $AMGN - MarketBeat
Marshall Financial Group LLC Purchases New Position in Amgen Inc. $AMGN MarketBeat
Amgen at the Milken Future of Health Summit 2025 - Amgen
Amgen at the Milken Future of Health Summit 2025 Amgen
Amgen's Repatha Cuts Risk Of First Major Cardiovascular Event By 31% In High-Risk Patients - TradingView
Amgen's Repatha Cuts Risk Of First Major Cardiovascular Event By 31% In High-Risk Patients TradingView
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know Yahoo Finance
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - Yahoo Finance
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know Yahoo Finance
AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS - PR Newswire
AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS PR Newswire
Amgen Q4 results beat Street estimates, company says patients need weight-loss options - Reuters
Amgen Q4 results beat Street estimates, company says patients need weight-loss options Reuters
Amgen buys protein-degrading startup Dark Blue for up to $840M - BioPharma Dive
Amgen buys protein-degrading startup Dark Blue for up to $840M BioPharma Dive
Ro partners with Amgen to study barriers to obesity care, GLP-1 access - Reuters
Ro partners with Amgen to study barriers to obesity care, GLP-1 access Reuters